Skip to Content

Hubei Minkang Pharmaceutical Ltd HBMK

Rating as of

Morningstar’s Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Company Profile

Business Description

Hubei Minkang Pharmaceutical Ltd is a pharmaceutical company that mainly produces and markets Traditional Chinese Medicine (TCM) and some chemical pharmaceuticals, which are purchased over-the-counter (OTC) and by prescription. The company produces different types of products which include pills, tablets, capsules, granules, oral liquids, syrups, mixtures, and injections, in various formulations and dosages. It markets its products in China, US, Japan, Canada, Singapore, Malaysia, Thailand and Hong Kong among other countries under the brand name MinKang. The company mainly operates its business through its subsidiary HBMK Pharmaceutical Limited. The majority of the company's revenue comes from China.

No. 50 Xiba Road, Hubei Province
Yichang, China, People's Republic of
T +86 7176272393
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Sep 30, 2014
Fiscal Year End Dec 31, 2020
Stock Type Speculative Growth
Employees 472